HSPA1A and neoplasm: Thus, HSP70 inhibitors could be used as a single agent especially in cancers where HSP70 levels correlate with a poor prognosis6, 11, or in combination with an HSP90 inhibitor or chemotherapy to achieve enhanced apoptosis in tumours.